Site last updated:
December 2011
Cancer Services Forum currently has 1452 registered members
New cancer medicines: Joint working between the NHS and the pharmaceutical industry
Share
Future challenges for access to new cancer medicines
The afternoon was opened up by Professor John Burn (Lead Clinician, NHS North East) who gave an excellent presentation, elegantly and eloquently linking the latest developments in genetics and genetic testing with the issues surrounding drug development and then market access for new drugs.
He described some of the trial work that the Newcastle Genetics Lab has been doing and leading on, and gave an insight into new cancer medicines on the horizon that have been developed with genetic input.
Page 7 of 14
Discussion.